| Date Filed | Type | Description |
| 07/05/2023 |
4
| van der Vaart Sandra D (EVP, Chief Legal Officer) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 6,207 restricted stock units
@ $0 |
|
| 07/03/2023 |
4
| van der Vaart Sandra D (EVP, Chief Legal Officer) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Sold 212 shares
@ $240, valued at
$50.9k
|
|
| 06/09/2023 |
3
| van der Vaart Sandra D (President and Secretary) has filed a Form 3 on Fortrea Holdings Inc. |
| 04/03/2023 |
4
| van der Vaart Sandra D (EVP, Chief Legal Officer) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 3,609 shares
@ $0
Paid exercise price by delivering 1,371 shares
@ $224.7, valued at
$308.1k
|
|
| 02/14/2023 |
4
| van der Vaart Sandra D (EVP, Chief Legal Officer) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Paid exercise price by delivering 78 shares
@ $248.13, valued at
$19.4k
Exercised 290 restricted stock units
@ $0 |
|
| 02/09/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2023 |
4
| van der Vaart Sandra D (EVP, Chief Legal Officer) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Paid exercise price by delivering 81 shares
@ $244.5, valued at
$19.8k
Exercised 300 restricted stock units
@ $0 |
|
| 02/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/31/2022 |
4
| van der Vaart Sandra D (EVP, Chief Legal Officer) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Sold 2,449 shares
@ $277.11, valued at
$678.6k
|
|
| 03/29/2022 |
4
| van der Vaart Sandra D (EVP, Chief Legal Officer) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 4,241 shares
@ $0
Paid exercise price by delivering 1,792 shares
@ $276.42, valued at
$495.3k
|
|
| 02/17/2022 |
4
| van der Vaart Sandra D (EVP, Chief Legal Officer) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Sold 207 shares
@ $273.98, valued at
$56.7k
|
|
| 02/15/2022 |
4
| van der Vaart Sandra D (EVP, Chief Legal Officer) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Paid exercise price by delivering 77 shares
@ $272.68, valued at
$21k
Granted 870 restricted stock units
@ $0
Granted 3,100 options to buy
@ $276.26, valued at
$856.4k
Exercised 284 restricted stock units
@ $0 |
|
| 02/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/26/2020 |
4
| van der Vaart Sandra D (EVP, Chief Legal Officer) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Sold 436 shares
@ $160.33, valued at
$69.9k
|
|
| 04/01/2020 |
4
| van der Vaart Sandra D (EVP, Chief Legal Officer) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 3,721 shares
@ $0
Paid exercise price by delivering 1,106 shares
@ $131.95, valued at
$145.9k
|
|
| 02/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2020 |
4/A
| van der Vaart Sandra D (SVP, Global General Counsel) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 900 restricted stock units
@ $0
Granted 3,900 options to buy
@ $182.51, valued at
$711.8k
|
|
| 02/06/2020 |
4
| van der Vaart Sandra D (SVP, Global General Counsel) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 840 restricted stock units
@ $0
Granted 3,600 options to buy
@ $182.51, valued at
$657k
|
|
| 07/10/2019 |
4
| van der Vaart Sandra D (SVP, Global General Counsel) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Sold 2,328 shares
@ $176.75, valued at
$411.5k
|
|
| 04/03/2019 |
4
| van der Vaart Sandra D (SVP, Global General Counsel) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 5,530 shares
@ $0
Paid exercise price by delivering 1,782 shares
@ $154.79, valued at
$275.8k
|
|
| 02/22/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/07/2016 |
3
| van der Vaart Sandra D (Director) has filed a Form 3 on SEQUENOM INC |